Court Blocks Advisory Panel's Move to End Newborn Hepatitis B Vaccine
A judge temporarily blocked an advisory committee's vote to end newborn hepatitis B vaccine recommendations.
Event / Health
A JAMA study found parental refusals of routine newborn vitamin K injections nearly doubled from 2.9% to 5.2% between 2017 and 2024. Eight infant deaths from vitamin K deficiency bleeding were reported in Idaho over 13 months. Amid broader vaccine hesitancy trends, a federal advisory committee under Health Secretary RFK Jr. voted to end routine newborn hepatitis B vaccination, though a federal judge temporarily blocked that decision.
2026-08-19 to 2026-11-16 · UTC publication dates
Coverage begins 21 Mar, 22:55 UTC
Follow the documented timeline or explore the related reporting.
A federal judge issued a temporary block on all decisions made by the reconfigured federal advisory committee whose members were appointed by Health Secretary Robert F. Kennedy Jr., including the vote to end the recommendation for routine newborn hepatitis B vaccination.
Research shows that newborns who do not receive a vitamin K shot are 81 times more likely to develop severe vitamin K deficiency bleeding than those who do. Before vitamin K injections became routine, up to approximately 1 in 60 babies suffered such bleeding, which can affect the brain and gastrointestinal tract.
At a February meeting of the Idaho chapter of the American Academy of Pediatrics, physicians reported knowing of eight deaths from vitamin K deficiency bleeding in Idaho over the preceding 13 months, a figure attributed in part to rising parental refusals of the routine newborn shot.
A study published in the Journal of the American Medical Association, analyzing more than 5 million births nationwide in the United States, found that parental refusals of vitamin K shots for newborns nearly doubled between 2017 and 2024, rising from 2.9% to 5.2%.
Vitamin K injections for newborns have been a routine preventive measure in the United States since 1961, administered to prevent potentially life-threatening bleeding caused by low vitamin K levels at birth. Infants cannot produce sufficient vitamin K from their intestines until they begin eating solid foods at around 6 months of age.
Research indicates that parents who decline the newborn vitamin K shot are much more likely to also refuse the hepatitis B vaccine at birth and erythromycin eye ointment, which protects against gonorrheal eye infections that can cause blindness. Rates of hepatitis B vaccination at birth have dropped in recent years.
A federal advisory committee, whose members were appointed by Health Secretary Robert F. Kennedy Jr., voted to end the longstanding recommendation to immunize all newborns against hepatitis B at birth. A federal judge subsequently issued a temporary block on all decisions made by the reconfigured committee.
A judge temporarily blocked an advisory committee's vote to end newborn hepatitis B vaccine recommendations.
Newborn vitamin K refusals nearly doubled since 2017, raising bleeding risk 81-fold and linked to eight infant deaths in Idaho.